Literature DB >> 12406675

Overexpression of DsbC and DsbG markedly improves soluble and functional expression of single-chain Fv antibodies in Escherichia coli.

Zhong Zhang1, Zhi-Hua Li, Fei Wang, Min Fang, Chang-Cheng Yin, Zhi-Yong Zhou, Qing Lin, Hua-Liang Huang.   

Abstract

Single-chain Fv antibodies (scFv), a group of reconstructed molecules with several disulfide bonds, are prone to aggregate as inclusion bodies, the insoluble species of natural proteins, when expressed in Escherichia coli, especially at high level. Recovery of functionally active products from inclusion bodies is onerous and ineffective. We have increased the soluble and functional scFv yields by fusing either DsbC or DsbG, two E. coli disulfide isomerases with general chaperone function, to scFvs. Compared to the totally insoluble inclusion bodies of scFvs expressed separately, more than half of each fusion protein DsbC-scFv or DsbG-scFv was soluble, according to SDS-PAGE analysis. The more effective solubility was obtained when the fused protein DsbG-scFv was co-expressed simultaneously with DsbC under the same promoter. Under this condition, the soluble portion of DsbG-scFv increased from about 50% to 90% measured by scanning SDS-PAGE gel. Co-expression of DsbC can change fusion protein CBD-scFv from totally insoluble when expressed in E. coli separately to a considerable portion of soluble CBD-scFv. Antigen-binding activity assay showed that scFvs retained full affinity to specific antigens. We also determined that general molecular chaperones GroEL and GroES had no effects on the solubility of scFvs when co-expressed with scFv in E. coli. We propose that the correct formation of disulfide bonds in scFvs is the crucial factor responsible for solubility of scFvs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406675     DOI: 10.1016/s1046-5928(02)00502-8

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  18 in total

1.  Expression of human proteins at the Southeast Collaboratory for Structural Genomics.

Authors:  Michael R Mayer; Tamara A Dailey; Clay M Baucom; Jill L Supernak; Michael C Grady; Harris E Hawk; Harry A Dailey
Journal:  J Struct Funct Genomics       Date:  2004

2.  A novel bispecific antibody, BiSS, with potent anti-cancer activities.

Authors:  Bin Dong; Changhua Zhou; Ping He; Jing Li; Siqi Chen; Ji Miao; Qing Li; Zhong Wang
Journal:  Cancer Biol Ther       Date:  2016-02-01       Impact factor: 4.742

3.  Effect of osmotic stress and heat shock in recombinant protein overexpression and crystallization.

Authors:  Natalia Oganesyan; Irina Ankoudinova; Sung-Hou Kim; Rosalind Kim
Journal:  Protein Expr Purif       Date:  2006-10-10       Impact factor: 1.650

4.  Role of dimerization in the catalytic properties of the Escherichia coli disulfide isomerase DsbC.

Authors:  Silvia A Arredondo; Tiffany F Chen; Austen F Riggs; Hiram F Gilbert; George Georgiou
Journal:  J Biol Chem       Date:  2009-07-06       Impact factor: 5.157

Review 5.  Protein folding and aggregation in bacteria.

Authors:  Raimon Sabate; Natalia S de Groot; Salvador Ventura
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

6.  Co-expression of Dsb proteins enables soluble expression of a single-chain variable fragment (scFv) against human type 1 insulin-like growth factor receptor (IGF-1R) in E. coli.

Authors:  Xue-Wen Sun; Xiao-Hua Wang; Yan-Bing Yao
Journal:  World J Microbiol Biotechnol       Date:  2014-09-26       Impact factor: 3.312

7.  Coexpression of molecular chaperones to enhance functional expression of anti-BNP scFv in the cytoplasm of Escherichia coli for the detection of B-type natriuretic peptide.

Authors:  Bo Hee Maeng; Dong Hyun Nam; Yong Hwan Kim
Journal:  World J Microbiol Biotechnol       Date:  2010-10-20       Impact factor: 3.312

8.  Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodies.

Authors:  Tomohiro Makino; Georgios Skretas; Tae-Hyun Kang; George Georgiou
Journal:  Metab Eng       Date:  2010-12-03       Impact factor: 9.783

Review 9.  Overcoming the Solubility Problem in E. coli: Available Approaches for Recombinant Protein Production.

Authors:  Claudia Ortega; Pablo Oppezzo; Agustín Correa
Journal:  Methods Mol Biol       Date:  2022

10.  Targeting TNF-alpha with a tetravalent mini-antibody TNF-TeAb.

Authors:  Mengyuan Liu; Xiangbin Wang; Changcheng Yin; Zhong Zhang; Qing Lin; Yongsu Zhen; Hualiang Huang
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.